Antidemenia Agents are Partially Symptomatic Treatment and Partially Disease Modifying Treatment

DOI Open Access

Description

Antidementia agents, i.e., cholinesterase inhibitors (ChEIs) and N-methyl-D-aspartate (NMDA) receptor (NMDA-R) antagonist are now considered to be symptomatic treatment. However, ChEIs and NMDA-R antagonist are proven to have neuroprotecting actions against amyloid pathology

Journal

Details 詳細情報について

Report a problem

Back to top